Pharmaceuticals (Dec 2009)

Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases

  • Mercè Pallàs,
  • Daniel Ortuño-Sahagún,
  • Argelia E. Rojas-Mayorquín,
  • Carlos Beas-Zarate,
  • Ester Verdaguer,
  • Antoni Camins,
  • Felix Junyent

DOI
https://doi.org/10.3390/ph2030194
Journal volume & issue
Vol. 2, no. 3
pp. 194 – 205

Abstract

Read online

The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the development of effective drugs for aging prevention is a knowledge of the biochemical pathways responsible for the cellular aging process. In this context it seems clear that free radicals play a key role in the aging process. However, in recent years it has been demonstrated that the families of enzymes called sirtuins, specifically situin 1 (SIRT1), have an anti-aging action. Thus, the natural compound resveratrol is a natural compound that shows a very strong activation of SIRT1 and also shows antioxidant effects. By activating sirtuin 1, resveratrol modulates the activity of numerous proteins, including peroxisome proliferator-activated receptor coactivator-1α (PGC-1 alpha), the FOXO family, Akt (protein kinase B) and NFκβ. In the present review, we suggest that resveratrol may constitute a potential drug for prevention of ageing and for the treatment of several diseases due to its antioxidant properties and sirtuin activation.

Keywords